Skip to main content
Register for FutureLink Barcelona 2026 Today→
TraceLink — Network for Greater Good
AI Mode Agents AI Solutions Network Resources About
LOG IN TraceLink Classic OPUS Platform
Resources

Breadcrumb

  1. Home
  2. Resources
  3. Resource Center

Top U.S. Pharmacy Services Provider Chooses TraceLink to Expand 340B

banner-image
  • Download PDF
  • Share
    • LinkedIn
    • Facebook
    • Mail
    • Twitter

Table of contents

An integrated pharmacy services provider chose TraceLink to enable digital shipment data exchange with their Covered Entity network and automate their 340B replenishment receiving workflow. This reduces staff burden and supports flexibility across 340B models, enabling care for uninsured and low-income patients. 

Customer Business Challenges
• Supporting varied 340B distribution models requires operational flexibility.
• Limited digital connectivity for shipping transactions impacts automation and efficiency.
• Manually performing receiving workflows detracts staff time from higher-value work.

The Solution
• Collaborating with the Covered Entity network by exchanging digitalized shipment data.
• A fully automated replenishment receiving workflow eliminates manual steps and frees staff.
• A scalable operating model helps deliver high-quality care to 340B patient populations.

Download the OPUS Orchestration Journey to learn more.

<a href="/category/opus-orchestration-journey" hreflang="en">OPUS Orchestration Journey</a><a href="/category/mint-logistics" hreflang="en">MINT for Logistics</a><a href="/category/dscsa" hreflang="en">DSCSA</a>, <a href="/category/supply-chain-digitalization" hreflang="en">Supply Chain Digitalization</a><a href="/category/regulatory-compliance" hreflang="en">Regulatory/Compliance</a>

Table of contents

Subscribe to Agile Supply Chain Insights
Subscribe to stay informed with the latest patient-centric agile supply chain thought leadership content.
Related Content
DSCSA
Maximize Pharmacy Efficiency: Achieve DSCSA Compliance for 340B Inventory Without Disrupting Operations
See how manufacturers and 3PLs can get the real-time visibility they need to achieve best-in-class on-time, in-full customer shipment performance. Watch the webinar now!
View More
dispenser_prescription_bottles_resource.jpg
How Will Serialization Affect 340B Pharmacies?
Learn how the addition of serialized product identifiers creates new possibilities for 340B participants to address a potential “gap” in DSCSA compliance when managing 340B product.
View More
For Internal 60
340B Under DSCSA: Why a Network is Critical for Efficient 340B Shipping and Receiving
The industry has yet to agree upon a common model for handling 340B product under DSCSA. Watch this webinar for a deep dive into some of the approaches.
View More

Cookie Settings

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies or similar tracking technologies. Please see below for an overview of the categories of cookies and similar technologies used on this site. You can allow or deny some of all of them, except Strictly Necessary Cookies which are required to provide the site to you. However, blocking some types of cookies may impact your experience of the site and services we are able to offer.

Please see our Cookie Policy for more details, including a list of the cookies we use. You can change your consent options at any time by following the “Cookie Settings” link in the Cookie Policy.
'Strictly Necessary' cookies let you move around the Site and use essential features like secure areas, shopping baskets and online billing. Without these cookies you would not be able to navigate between pages or use certain vital features of our Site, so we do not require your consent for their use. These cookies don't gather any information about you that could be used for marketing or remembering where you've been on the internet. For example, we use these Strictly Necessary cookies to identify you as being logged in to the Site. You can set your browser to block or alert you about these cookies, but if you do so, some parts of the Site will not work.
'Performance' cookies collect information about how you use the Site, such as which pages you visit, the time spent on the Site and if you experience any errors. We use performance cookies to provide aggregated statistics on how the Site is used and help us improve the Site including by measuring any errors that occur.
'Functional' cookies are used to provide services or to remember settings to improve your visit. We use 'Functionality' cookies to remember your settings and choices and show you when you're logged in to the Site.
‘Targeting' cookies are linked to services provided by third parties, such as 'Like' buttons and 'Share' buttons. The third party provides these services in return for recognizing that you have visited the Site. We also use 'Targeting' cookies to gather information that could be used to display content that we think may interest you.
Register for FutureLink Barcelona 2026 Today→
TraceLink — Network for Greater Good
Log In OPUS Platform · TraceLink Classic
AI Mode
Featured Report The Agentic Supply Chain Operating Model →

Agentic Business Processes

External Manufacturing Logistics Transportation Commerce Compliance

Products

Digital Transaction Exchange Process Collaboration Global Track-and-Trace Regulatory Compliance Real-Time Intelligence

Resources

Resource Center TraceLink University Partners Community Customers Events

About TraceLink

Company Overview Newsroom Culture & Careers Open Jobs Legal & Trust Center Corporate Social Responsibility Network Directory Glossary

Hot Topics

Eliminate Stockouts Improve OTIF Reduce Costs Increase End-to-End Visibility Accelerate Order-to-Cash Optimize Inventory Levels Scale Cross-Partner Execution
Need assistance? Contact Technical Support→

Contact Us Today

Transform your supply chain operations with a human-agent workforce.

Contact Us →

Stay Up-to-Date

Subscribe to receive industry insights and evolving trends.

Thanks — you're subscribed.

© TraceLink Inc. 2009–2026 All Rights Reserved